Literature DB >> 27780865

Natural and Induced Mitochondrial Phosphate Carrier Loss: DIFFERENTIAL DEPENDENCE OF MITOCHONDRIAL METABOLISM AND DYNAMICS AND CELL SURVIVAL ON THE EXTENT OF DEPLETION.

Erin L Seifert1, Aniko Gál2, Michelle G Acoba3, Qipei Li2, Lauren Anderson-Pullinger2, Tunde Golenár2, Cynthia Moffat2, Neal Sondheimer4, Steven M Claypool3, György Hajnóczky5.   

Abstract

The relevance of mitochondrial phosphate carrier (PiC), encoded by SLC25A3, in bioenergetics is well accepted. However, little is known about the mechanisms mediating the cellular impairments induced by pathological SLC25A3 variants. To this end, we investigated the pathogenicity of a novel compound heterozygous mutation in SLC25A3 First, each variant was modeled in yeast, revealing that substituting GSSAS for QIP within the fifth matrix loop is incompatible with survival on non-fermentable substrate, whereas the L200W variant is functionally neutral. Next, using skin fibroblasts from an individual expressing these variants and HeLa cells with varying degrees of PiC depletion, PiC loss of ∼60% was still compatible with uncompromised maximal oxidative phosphorylation (oxphos), whereas lower maximal oxphos was evident at ∼85% PiC depletion. Furthermore, intact mutant fibroblasts displayed suppressed mitochondrial bioenergetics consistent with a lower substrate availability rather than phosphate limitation. This was accompanied by slowed proliferation in glucose-replete medium; however, proliferation ceased when only mitochondrial substrate was provided. Both mutant fibroblasts and HeLa cells with 60% PiC loss showed a less interconnected mitochondrial network and a mitochondrial fusion defect that is not explained by altered abundance of OPA1 or MFN1/2 or relative amount of different OPA1 forms. Altogether these results indicate that PiC depletion may need to be profound (>85%) to substantially affect maximal oxphos and that pathogenesis associated with PiC depletion or loss of function may be independent of phosphate limitation when ATP requirements are not high.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  confocal microscopy; energy metabolism; live cell imaging; mitochondria; mitochondrial disease; mitochondrial dynamics; mitochondrial transport

Mesh:

Substances:

Year:  2016        PMID: 27780865      PMCID: PMC5207081          DOI: 10.1074/jbc.M116.744714

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  OPA1 cleavage depends on decreased mitochondrial ATP level and bivalent metals.

Authors:  Laurent Baricault; Bruno Ségui; Laurie Guégand; Aurélien Olichon; Annie Valette; Florence Larminat; Guy Lenaers
Journal:  Exp Cell Res       Date:  2007-08-19       Impact factor: 3.905

2.  Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation.

Authors:  Johannes A Mayr; Olaf Merkel; Sepp D Kohlwein; Boris R Gebhardt; Hansjosef Böhles; Ulrike Fötschl; Johannes Koch; Michaela Jaksch; Hanns Lochmüller; Rita Horváth; Peter Freisinger; Wolfgang Sperl
Journal:  Am J Hum Genet       Date:  2007-01-10       Impact factor: 11.025

3.  Expression in Escherichia coli, functional characterization, and tissue distribution of isoforms A and B of the phosphate carrier from bovine mitochondria.

Authors:  G Fiermonte; V Dolce; F Palmieri
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

4.  Tissue-specific expression of the two isoforms of the mitochondrial phosphate carrier in bovine tissues.

Authors:  V Dolce; G Fiermonte; F Palmieri
Journal:  FEBS Lett       Date:  1996-12-09       Impact factor: 4.124

5.  Pathologic Variants of the Mitochondrial Phosphate Carrier SLC25A3: Two New Patients and Expansion of the Cardiomyopathy/Skeletal Myopathy Phenotype With and Without Lactic Acidosis.

Authors:  E J Bhoj; M Li; R Ahrens-Nicklas; L C Pyle; J Wang; V W Zhang; C Clarke; L J Wong; N Sondheimer; C Ficicioglu; M Yudkoff
Journal:  JIMD Rep       Date:  2015-02-15

6.  Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency.

Authors:  Werner J H Koopman; Henk-Jan Visch; Sjoerd Verkaart; Lambertus W P J van den Heuvel; Jan A M Smeitink; Peter H G M Willems
Journal:  Am J Physiol Cell Physiol       Date:  2005-05-18       Impact factor: 4.249

7.  Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin.

Authors:  Steven M Claypool; Bonny L Dickinson; Masaru Yoshida; Wayne I Lencer; Richard S Blumberg
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

8.  Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells.

Authors:  Sumana Santra; Robert W Gilkerson; Mercy Davidson; Eric A Schon
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

9.  Phenotypic Screening for Friedreich Ataxia Using Random shRNA Selection.

Authors:  M Grazia Cotticelli; Fabio Acquaviva; Shujuan Xia; Avinash Kaur; Yongping Wang; Robert B Wilson
Journal:  J Biomol Screen       Date:  2015-08-18

10.  Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins.

Authors:  Steven M Claypool; J Michael McCaffery; Carla M Koehler
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

View more
  8 in total

1.  The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis.

Authors:  Aren Boulet; Katherine E Vest; Margaret K Maynard; Micah G Gammon; Antoinette C Russell; Alexander T Mathews; Shelbie E Cole; Xinyu Zhu; Casey B Phillips; Jennifer Q Kwong; Sheel C Dodani; Scot C Leary; Paul A Cobine
Journal:  J Biol Chem       Date:  2017-12-13       Impact factor: 5.157

Review 2.  Molecular regulation of MCU: Implications in physiology and disease.

Authors:  Neeharika Nemani; Santhanam Shanmughapriya; Muniswamy Madesh
Journal:  Cell Calcium       Date:  2018-06-27       Impact factor: 6.817

3.  Identification of Lactate-Related Gene Signature for Prediction of Progression and Immunotherapeutic Response in Skin Cutaneous Melanoma.

Authors:  Yalin Xie; Jie Zhang; Mengna Li; Yu Zhang; Qian Li; Yue Zheng; Wei Lai
Journal:  Front Oncol       Date:  2022-02-21       Impact factor: 6.244

Review 4.  Mitochondrial H+ Leak and Thermogenesis.

Authors:  Ambre M Bertholet; Yuriy Kirichok
Journal:  Annu Rev Physiol       Date:  2021-11-10       Impact factor: 22.163

Review 5.  Prime Real Estate: Metals, Cofactors and MICOS.

Authors:  Amy E Medlock; J Catrice Hixon; Tawhid Bhuiyan; Paul A Cobine
Journal:  Front Cell Dev Biol       Date:  2022-05-20

Review 6.  The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases.

Authors:  Camilla Ceccatelli Berti; Giulia di Punzio; Cristina Dallabona; Enrico Baruffini; Paola Goffrini; Tiziana Lodi; Claudia Donnini
Journal:  Genes (Basel)       Date:  2021-02-20       Impact factor: 4.096

7.  Mitochondrial copper and phosphate transporter specificity was defined early in the evolution of eukaryotes.

Authors:  Xinyu Zhu; Aren Boulet; Katherine M Buckley; Casey B Phillips; Micah G Gammon; Laura E Oldfather; Stanley A Moore; Scot C Leary; Paul A Cobine
Journal:  Elife       Date:  2021-02-16       Impact factor: 8.140

8.  Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischemia.

Authors:  M Kerr; K M J H Dennis; C A Carr; W Fuller; G Berridge; S Rohling; C L Aitken; C Lopez; R Fischer; J J Miller; K Clarke; D J Tyler; L C Heather
Journal:  FASEB J       Date:  2021-08       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.